ReviewCurrent nutrition reports2026
Neurobiological Consequences of High-Fat High-Sugar Diets on the Mesocorticolimbic System: a Narrative Review.
Review in Current nutrition reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Endogenous Opioid System in Compulsive Eating.Brain sciences · 2026Review
- Distractor effect of food stimuli among patients with binge eating behaviour - a narrative review and pilot data.Reviews in endocrine & metabolic disorders · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis narrative review aims to examine the neurobiological consequences of high-fat, high-sugar (HFHS) diets on the mesocorticolimbic reward system. Emphasis is placed on how dopamine and opioid signaling interact to drive maladaptive behaviors such as compulsive eating and food addiction. RECENT
findingsHigh-fat, high-sugar (HFHS) diets have a profound impact on the mesocorticolimbic reward system, altering the function of both dopamine and opioid signaling. Evidence from animal and human studies shows that acute consumption of HFHS foods produces supra-additive effects, boosting dopamine release in the Ventral Tegmental Area-Nucleus Accumens (VTA-NAc) pathway and enhancing pleasure through µ-opioid receptor activation, which reinforces repeated intake. Chronic exposure, however, results in maladaptive neuroplasticity, including downregulation of D2 receptors, weakened dopamine signaling, synaptic desensitization, and structural impairments in the prefrontal cortex. These changes parallel neural adaptations observed in substance use disorders, manifesting as tolerance, loss of control, and cue-induced craving. The opioid system also contributes to stress-related comfort eating. In contrast, individual variability in response to treatments such as the opioid antagonist naltrexone has been linked to genetic factors, including Opioid Receptor Mu 1 (OPRM1) polymorphisms. HFHS diets profoundly reshape the brain's reward circuitry, promoting tolerance, craving, and compulsive consumption that mirror substance addiction. These findings support the conceptualization of food addiction as a neurobiological condition and highlight the importance of personalized treatment approaches. A better understanding of dopaminergic and opioid system interactions will inform targeted interventions to prevent and manage diet-related obesity and eating disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.